You are here

Resource Center

AdvaMed Comments on Docket No. FDA-2018-D-0944; Draft Guidance for Industry; Investigational In Vitro Diagnostics in Oncology Trials: Streamlined Submission Process for Study Risk Determination

Comments

application/pdf - 788.49 kB
Date:
06/25/2018
Disease Area: